Advanced Medical Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Hidradenitis suppurativa2 trials

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed5 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Novartis Pharmaceuticals2 trials

Closed trials

• Completed

  A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

  NCT05372419· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

  NCT05369403· Phase 3· Eli Lilly and Company· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source

• Completed

  Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

  NCT04179175· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT03827798· Phase 2· Novartis Pharmaceuticals· Source